Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
About this study
The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.
- Condition
- Rectal Neoplasms
- Tested
- Registry study, no specific intervention
- Sponsor
- Peking Union Medical College Hospital
Who can join
- Age
- Not specified
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 3
- Study condition: Rectal Neoplasms
- pathologically confirmed rectal adenocarcinoma
- located within 12cm below the anal verge
Exclusion 4
- diagnosed with distant metastasis
- multiple primary colorectal cancers
- history of previous malignant tumors
- Pregnant or lactating women
Where
1 site, 1 recruiting
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Contact
-
Yi Xiao, Professor
+86 13366036387 Xiaoy@pumch.cn
Potential match only. Final eligibility is determined by the study team.